Gene · 1270
Papers4,359
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,359
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retinoprotective compounds, current efficacy, and future prospective. | Neural Regen Res | 2023 | 37449599 | PubTator, text mining | PubMed |
| Exploring the Communication of the SASP: Dynamic, Interactive, and Adaptive Effects on the Microenvironment. | Int J Mol Sci | 2023 | 37445973 | PubTator, text mining | PubMed |
| Loss of TDP-43 oligomerization or RNA binding elicits distinct aggregation patterns. | EMBO J | 2023 | 37431963 | PubTator, text mining | PubMed |
| Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives. | Iran J Basic Med Sci | 2023 | 37427325 | PubTator, text mining | PubMed |
| Neural lineage differentiation of human pluripotent stem cells: Advances in disease modeling. | World J Stem Cells | 2023 | 37424945 | PubTator, text mining | PubMed |
| Molecular mechanisms controlling vertebrate retinal patterning, neurogenesis, and cell fate specification. | Trends Genet | 2023 | 37423870 | PubTator, text mining | PubMed |
| Recapitulation of pathophysiological features of AD in SARS-CoV-2-infected subjects. | Elife | 2023 | 37417740 | PubTator, text mining | PubMed |
| Reactive astrocytes mediate TSPO overexpression in response to sustained CNTF exposure in the rat striatum. | Mol Brain | 2023 | 37408083 | PubTator, text mining | PubMed |
| Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions. | Invest Ophthalmol Vis Sci | 2023 | 37389545 | PubTator, text mining | PubMed |
| Effectiveness of Secretome from Human Umbilical Cord Mesenchymal Stem Cells in Gel (10% SM-hUCMSC Gel) for Chronic Wounds (Diabetic and Trophic Ulcer) - Phase 2 Clinical Trial. | J Multidiscip Healthc | 2023 | 37383529 | PubTator, text mining | PubMed |
| Biological insights in non-small cell lung cancer. | Cancer Biol Med | 2023 | 37381723 | PubTator, text mining | PubMed |
| The Intricate Interplay between Cancer Stem Cells and Oncogenic miRNAs in Breast Cancer Progression and Metastasis. | Life (Basel) | 2023 | 37374142 | PubTator, text mining | PubMed |
| An In Vitro Alveolar Model Allows for the Rapid Assessment of Particles for Respiratory Sensitization Potential. | Int J Mol Sci | 2023 | 37373252 | PubTator, text mining | PubMed |
| Central and Peripheral Inflammation: A Common Factor Causing Addictive and Neurological Disorders and Aging-Related Pathologies. | Int J Mol Sci | 2023 | 37373230 | PubTator, text mining | PubMed |
| The Immunomodulatory Role of Cell-Free Approaches in SARS-CoV-2-Induced Cytokine Storm-A Powerful Therapeutic Tool for COVID-19 Patients. | Biomedicines | 2023 | 37371831 | PubTator, text mining | PubMed |
Astrocytes Differentiated from LRRK2-I1371V Parkinson's-Disease-Induced Pluripotent Stem Cells Exhibit Similar Yield but Cell-Intrinsic Dysfunction in Glutamate Uptake and Metabolism, ATP Generation, and Nrf2-Mediated Glutathione Machinery. | Cells | 2023 | 37371062 | PubTator, text mining | PubMed |
| The Role of Mesenchymal Stromal Cells and Their Products in the Treatment of Injured Spinal Cords. | Curr Issues Mol Biol | 2023 | 37367078 | PubTator, text mining | PubMed |
| Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out. | Diseases | 2023 | 37366867 | PubTator, text mining | PubMed |
| Analysis of age-dependent gene-expression in human tissues for studying diabetes comorbidities. | Sci Rep | 2023 | 37365269 | PubTator, text mining | PubMed |
| Spinal cord injury: molecular mechanisms and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37357239 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1270/papers?page=17